http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109364270-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-126 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-186 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-18 |
filingDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109364270-B |
titleOfInvention | Nuclear magnetic contrast agent with oligomer specificity and preparation method and application thereof |
abstract | The invention provides a nuclear magnetic contrast agent with oligomer specificity and a preparation method and application thereof, wherein the nuclear magnetic contrast agent with oligomer specificity comprises ferroferric oxide nanoparticles and single-chain antibodies, the ferroferric oxide nanoparticles are coated in polyethylene glycol dicarboxylic acid, and the single-chain antibodies are connected to the outer surface of the polyethylene glycol dicarboxylic acid. |
priorityDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.